Antharis Therapeutics, Inc. Information

Antharis Therapeutics is a multinational biopharmaceutical company developing new treatments for cancer, inflammatory and infectious diseases. In particular, our company utilizes cutting-edge science to develop therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs. The company, founded by Dr. Raphael R Pinaud in 2020, has significantly grown and successfully advanced its mission to date. Furthermore, Antharis strategically acquired Cassyni Biopharma and Galileo Biotech, in mid-2022 and mid-2023, respectively, to further and more effectively advance its mandate to bring transformational therapies to patients in need.